This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are
presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.
"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.
Num | microRNA | Gene | miRNA log2FC | miRNA pvalue | Gene log2FC | Gene pvalue | Interaction | Correlation beta | Correlation P-value | PMID | Reported in cancer studies |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | hsa-miR-148a-3p | ABCA1 | 1.27 | 0 | -0.71 | 0.00276 | MirTarget; miRNATAP | -0.13 | 0.00141 | NA | |
2 | hsa-miR-148a-3p | ABLIM3 | 1.27 | 0 | -1.3 | 0.00063 | miRNATAP | -0.27 | 8.0E-5 | NA | |
3 | hsa-miR-148a-3p | ACVR1 | 1.27 | 0 | -0.44 | 0.01143 | miRNAWalker2 validate; miRTarBase; MirTarget; miRNATAP | -0.11 | 0.00035 | NA | |
4 | hsa-miR-148a-3p | ADAM19 | 1.27 | 0 | -1.06 | 0.01895 | mirMAP | -0.19 | 0.01729 | NA | |
5 | hsa-miR-148a-3p | ADAMTS15 | 1.27 | 0 | -2.81 | 0 | MirTarget; miRNATAP | -0.43 | 5.0E-5 | NA | |
6 | hsa-miR-148a-5p | ADAMTS15 | 1.16 | 0.00015 | -2.81 | 0 | mirMAP | -0.33 | 0.0006 | NA | |
7 | hsa-miR-148a-3p | ADAMTS5 | 1.27 | 0 | -2.16 | 0 | miRNATAP | -0.22 | 0.00014 | NA | |
8 | hsa-miR-148a-5p | ADAMTS5 | 1.16 | 0.00015 | -2.16 | 0 | mirMAP; miRNATAP | -0.2 | 0.00011 | NA | |
9 | hsa-miR-148a-3p | ADARB1 | 1.27 | 0 | -1.93 | 0 | miRNAWalker2 validate; mirMAP | -0.31 | 0 | NA | |
10 | hsa-miR-148a-3p | ADCY9 | 1.27 | 0 | -1.5 | 0 | mirMAP | -0.2 | 2.0E-5 | NA | |
11 | hsa-miR-148a-3p | AHDC1 | 1.27 | 0 | -0.69 | 6.0E-5 | miRNATAP | -0.16 | 0 | NA | |
12 | hsa-miR-148a-5p | ALPK3 | 1.16 | 0.00015 | -1.02 | 0.00049 | mirMAP | -0.23 | 0 | NA | |
13 | hsa-miR-148a-3p | APC | 1.27 | 0 | -0.6 | 0.00012 | miRNAWalker2 validate | -0.12 | 2.0E-5 | NA | |
14 | hsa-miR-148a-3p | ARHGAP20 | 1.27 | 0 | -3.52 | 0 | miRNATAP | -0.38 | 0 | NA | |
15 | hsa-miR-148a-5p | ARHGAP29 | 1.16 | 0.00015 | -0.34 | 0.31665 | MirTarget | -0.11 | 0.04655 | NA | |
16 | hsa-miR-148a-3p | ARHGEF17 | 1.27 | 0 | -1.19 | 0 | miRNATAP | -0.24 | 0 | NA | |
17 | hsa-miR-148a-5p | ARID5B | 1.16 | 0.00015 | -1.57 | 0 | mirMAP | -0.13 | 0.00016 | NA | |
18 | hsa-miR-148a-3p | ARL10 | 1.27 | 0 | -1.12 | 0.00198 | mirMAP | -0.15 | 0.02153 | NA | |
19 | hsa-miR-148a-5p | ART4 | 1.16 | 0.00015 | -1.65 | 0.00419 | mirMAP | -0.27 | 0.00332 | NA | |
20 | hsa-miR-148a-3p | ATP11A | 1.27 | 0 | 0.53 | 0.06467 | MirTarget | -0.15 | 0.00339 | NA | |
21 | hsa-miR-148a-3p | ATP1A2 | 1.27 | 0 | -6.96 | 0 | MirTarget | -0.55 | 2.0E-5 | NA | |
22 | hsa-miR-148a-3p | ATP2B4 | 1.27 | 0 | -1.72 | 0 | MirTarget; miRNATAP | -0.34 | 0 | NA | |
23 | hsa-miR-148a-3p | B4GALT5 | 1.27 | 0 | -0.51 | 0.00437 | MirTarget; miRNATAP | -0.1 | 0.00109 | NA | |
24 | hsa-miR-148a-3p | BCL2L2 | 1.27 | 0 | -1.27 | 0 | miRNATAP | -0.18 | 0 | NA | |
25 | hsa-miR-148a-5p | BCL2L2 | 1.16 | 0.00015 | -1.27 | 0 | mirMAP | -0.14 | 0 | NA | |
26 | hsa-miR-148a-5p | BDNF | 1.16 | 0.00015 | -2.91 | 0 | mirMAP | -0.14 | 0.04454 | NA | |
27 | hsa-miR-148a-3p | BMPR2 | 1.27 | 0 | -0.59 | 4.0E-5 | mirMAP | -0.12 | 0 | NA | |
28 | hsa-miR-148a-3p | BTBD3 | 1.27 | 0 | -0.6 | 0.00457 | miRNAWalker2 validate; miRNATAP | -0.12 | 0.00126 | NA | |
29 | hsa-miR-148a-5p | C1orf21 | 1.16 | 0.00015 | -1.51 | 0 | mirMAP | -0.12 | 0.00081 | NA | |
30 | hsa-miR-148a-5p | CA12 | 1.16 | 0.00015 | -0.95 | 0.06698 | MirTarget | -0.18 | 0.02837 | NA | |
31 | hsa-miR-148a-3p | CAMK2A | 1.27 | 0 | -4.14 | 0 | miRNATAP | -0.45 | 1.0E-5 | NA | |
32 | hsa-miR-148a-3p | CCDC85C | 1.27 | 0 | -0.47 | 0.02313 | mirMAP | -0.14 | 0.00024 | NA | |
33 | hsa-miR-148a-5p | CD109 | 1.16 | 0.00015 | -0.51 | 0.31559 | mirMAP | -0.25 | 0.00143 | NA | |
34 | hsa-miR-148a-5p | CD44 | 1.16 | 0.00015 | -0.8 | 0.04276 | mirMAP | -0.18 | 0.00281 | 23861222 | In MHCC97H and MHCC97L cells over-expression of miR-148a blocked the EMT process attenuated the expression of CD90 and CD44 biomarkers for liver cancer stem cells and inhibited their migratory capacity |
35 | hsa-miR-148a-5p | CD93 | 1.16 | 0.00015 | -1.4 | 0 | mirMAP | -0.14 | 0.00109 | NA | |
36 | hsa-miR-148a-3p | CDC42BPB | 1.27 | 0 | -0.4 | 0.0008 | miRNATAP | -0.12 | 0 | NA | |
37 | hsa-miR-148a-3p | CFL2 | 1.27 | 0 | -2.62 | 0 | MirTarget; miRNATAP | -0.31 | 0 | NA | |
38 | hsa-miR-148a-3p | CHD5 | 1.27 | 0 | -3.46 | 0 | mirMAP | -0.25 | 0.00227 | NA | |
39 | hsa-miR-148a-3p | CHST3 | 1.27 | 0 | -0.88 | 0.0075 | mirMAP | -0.24 | 3.0E-5 | NA | |
40 | hsa-miR-148a-5p | CLIC4 | 1.16 | 0.00015 | -1.72 | 0 | mirMAP | -0.19 | 0.00016 | NA | |
41 | hsa-miR-148a-3p | CNN1 | 1.27 | 0 | -5.79 | 0 | miRNATAP | -0.6 | 0 | NA | |
42 | hsa-miR-148a-3p | COL4A1 | 1.27 | 0 | 0.15 | 0.58169 | miRNATAP | -0.23 | 0 | NA | |
43 | hsa-miR-148a-5p | COL5A2 | 1.16 | 0.00015 | 0.19 | 0.64093 | MirTarget | -0.2 | 0.00173 | NA | |
44 | hsa-miR-148a-3p | CPEB4 | 1.27 | 0 | -1.56 | 0 | miRNATAP | -0.23 | 0 | NA | |
45 | hsa-miR-148a-3p | CSF1 | 1.27 | 0 | -1.3 | 0.00033 | miRNATAP | -0.13 | 0.03825 | NA | |
46 | hsa-miR-148a-3p | CSPG4 | 1.27 | 0 | -1.78 | 0 | miRNATAP | -0.45 | 0 | NA | |
47 | hsa-miR-148a-3p | CYTH3 | 1.27 | 0 | -0.27 | 0.19343 | MirTarget; miRNATAP | -0.15 | 4.0E-5 | NA | |
48 | hsa-miR-148a-3p | DMPK | 1.27 | 0 | -1.53 | 0 | MirTarget | -0.23 | 0 | NA | |
49 | hsa-miR-148a-3p | DMXL1 | 1.27 | 0 | -0.95 | 0 | MirTarget; miRNATAP | -0.1 | 0.0003 | NA | |
50 | hsa-miR-148a-3p | DNAJB4 | 1.27 | 0 | -1.87 | 0 | miRNAWalker2 validate | -0.18 | 3.0E-5 | NA | |
51 | hsa-miR-148a-3p | DNAJC18 | 1.27 | 0 | -1.28 | 0 | MirTarget | -0.13 | 0.00025 | NA | |
52 | hsa-miR-148a-3p | DTNA | 1.27 | 0 | -4.06 | 0 | miRNATAP | -0.3 | 0.0042 | NA | |
53 | hsa-miR-148a-5p | EBF3 | 1.16 | 0.00015 | -2.22 | 0 | mirMAP | -0.12 | 0.02809 | NA | |
54 | hsa-miR-148a-5p | EDNRA | 1.16 | 0.00015 | -2.19 | 0 | mirMAP | -0.31 | 0 | NA | |
55 | hsa-miR-148a-3p | EGR3 | 1.27 | 0 | -4.25 | 0 | MirTarget | -0.22 | 0.00806 | NA | |
56 | hsa-miR-148a-3p | ELFN2 | 1.27 | 0 | -0.56 | 0.36612 | mirMAP | -0.31 | 0.00418 | NA | |
57 | hsa-miR-148a-3p | ENTPD1 | 1.27 | 0 | -1.12 | 0 | mirMAP | -0.13 | 7.0E-5 | NA | |
58 | hsa-miR-148a-5p | ENTPD1 | 1.16 | 0.00015 | -1.12 | 0 | mirMAP | -0.12 | 3.0E-5 | NA | |
59 | hsa-miR-148a-3p | EPAS1 | 1.27 | 0 | -0.53 | 0.02805 | miRNATAP | -0.16 | 0.00021 | NA | |
60 | hsa-miR-148a-5p | EPHA3 | 1.16 | 0.00015 | -3.18 | 0 | mirMAP | -0.23 | 0.00064 | NA | |
61 | hsa-miR-148a-3p | ERRFI1 | 1.27 | 0 | -1.11 | 0.00014 | MirTarget | -0.25 | 0 | NA | |
62 | hsa-miR-148a-3p | ESYT2 | 1.27 | 0 | -0.75 | 0 | mirMAP | -0.14 | 0 | NA | |
63 | hsa-miR-148a-3p | EXOC6B | 1.27 | 0 | -0.48 | 0.11834 | mirMAP | -0.16 | 0.00271 | NA | |
64 | hsa-miR-148a-3p | F3 | 1.27 | 0 | -1.93 | 0.00015 | MirTarget | -0.28 | 0.00187 | NA | |
65 | hsa-miR-148a-3p | FAM168B | 1.27 | 0 | -0.95 | 0 | MirTarget | -0.14 | 0 | NA | |
66 | hsa-miR-148a-5p | FGF2 | 1.16 | 0.00015 | -3.46 | 0 | mirMAP | -0.18 | 0.00879 | NA | |
67 | hsa-miR-148a-5p | FLRT2 | 1.16 | 0.00015 | -2.62 | 0 | mirMAP | -0.22 | 0.01293 | NA | |
68 | hsa-miR-148a-3p | FOXF1 | 1.27 | 0 | -3.6 | 0 | MirTarget | -0.28 | 6.0E-5 | NA | |
69 | hsa-miR-148a-3p | FOXK1 | 1.27 | 0 | -0.29 | 0.13213 | mirMAP | -0.11 | 0.00132 | NA | |
70 | hsa-miR-148a-5p | FRMD6 | 1.16 | 0.00015 | -0.93 | 0.00183 | miRNATAP | -0.12 | 0.01015 | NA | |
71 | hsa-miR-148a-5p | FSTL1 | 1.16 | 0.00015 | -1.2 | 3.0E-5 | mirMAP | -0.15 | 0.00126 | NA | |
72 | hsa-miR-148a-3p | FYCO1 | 1.27 | 0 | -1.62 | 0 | mirMAP | -0.26 | 0 | NA | |
73 | hsa-miR-148a-5p | GALNT10 | 1.16 | 0.00015 | -0.21 | 0.41329 | mirMAP | -0.14 | 0.00044 | NA | |
74 | hsa-miR-148a-3p | GFOD1 | 1.27 | 0 | -0.94 | 0.00661 | mirMAP | -0.17 | 0.00663 | NA | |
75 | hsa-miR-148a-5p | GNAL | 1.16 | 0.00015 | -3.91 | 0 | mirMAP | -0.2 | 0.00873 | NA | |
76 | hsa-miR-148a-5p | GNAO1 | 1.16 | 0.00015 | -3.6 | 0 | mirMAP | -0.26 | 0.00069 | NA | |
77 | hsa-miR-148a-5p | GNAQ | 1.16 | 0.00015 | -0.92 | 0 | mirMAP | -0.1 | 0.0002 | NA | |
78 | hsa-miR-148a-3p | GOLIM4 | 1.27 | 0 | -0.33 | 0.26739 | miRNAWalker2 validate | -0.14 | 0.01071 | NA | |
79 | hsa-miR-148a-5p | GPC4 | 1.16 | 0.00015 | -0.86 | 0.01858 | mirMAP | -0.14 | 0.013 | NA | |
80 | hsa-miR-148a-3p | GPRC5A | 1.27 | 0 | -1.04 | 0.01909 | MirTarget | -0.27 | 0.00059 | NA | |
81 | hsa-miR-148a-3p | GRIK3 | 1.27 | 0 | -4.42 | 0 | mirMAP | -0.28 | 0.00526 | NA | |
82 | hsa-miR-148a-3p | HIPK3 | 1.27 | 0 | -1.75 | 0 | MirTarget | -0.22 | 0.00095 | NA | |
83 | hsa-miR-148a-5p | IFFO2 | 1.16 | 0.00015 | -0.91 | 0.00201 | mirMAP | -0.11 | 0.01677 | NA | |
84 | hsa-miR-148a-5p | IGF1 | 1.16 | 0.00015 | -3.76 | 0 | mirMAP | -0.21 | 0.0237 | NA | |
85 | hsa-miR-148a-5p | IGF1R | 1.16 | 0.00015 | -0.49 | 0.0461 | mirMAP | -0.15 | 6.0E-5 | NA | |
86 | hsa-miR-148a-3p | IGF2 | 1.27 | 0 | 0.1 | 0.91238 | mirMAP | -0.41 | 0.00835 | NA | |
87 | hsa-miR-148a-3p | IL6ST | 1.27 | 0 | -2.1 | 2.0E-5 | MirTarget; miRNATAP | -0.3 | 0.00066 | NA | |
88 | hsa-miR-148a-3p | IRS1 | 1.27 | 0 | -0.85 | 0.00822 | miRNAWalker2 validate; miRTarBase | -0.13 | 0.01963 | NA | |
89 | hsa-miR-148a-3p | ITGA5 | 1.27 | 0 | -2.13 | 0 | miRNATAP | -0.34 | 0 | NA | |
90 | hsa-miR-148a-3p | ITGB8 | 1.27 | 0 | -0.77 | 0.0782 | miRNATAP | -0.17 | 0.03204 | NA | |
91 | hsa-miR-148a-3p | ITPK1 | 1.27 | 0 | -0.61 | 0.00024 | MirTarget; miRNATAP | -0.16 | 0 | NA | |
92 | hsa-miR-148a-5p | JAM2 | 1.16 | 0.00015 | -3.24 | 0 | miRNATAP | -0.13 | 0.04182 | NA | |
93 | hsa-miR-148a-5p | KATNAL1 | 1.16 | 0.00015 | -1.58 | 1.0E-5 | mirMAP | -0.14 | 0.01206 | NA | |
94 | hsa-miR-148a-3p | KCND3 | 1.27 | 0 | -4.09 | 0 | miRNATAP | -0.36 | 0.0007 | NA | |
95 | hsa-miR-148a-5p | KCND3 | 1.16 | 0.00015 | -4.09 | 0 | mirMAP | -0.24 | 0.01003 | NA | |
96 | hsa-miR-148a-3p | KCNQ5 | 1.27 | 0 | -3.67 | 0 | miRNATAP | -0.26 | 0.0268 | NA | |
97 | hsa-miR-148a-3p | KIAA0232 | 1.27 | 0 | -1.01 | 0 | MirTarget; miRNATAP | -0.14 | 0 | NA | |
98 | hsa-miR-148a-3p | KIAA0513 | 1.27 | 0 | -1.87 | 0 | mirMAP | -0.19 | 0.00013 | NA | |
99 | hsa-miR-148a-5p | KIAA1462 | 1.16 | 0.00015 | -1.72 | 0 | mirMAP | -0.26 | 0 | NA | |
100 | hsa-miR-148a-5p | KIAA1614 | 1.16 | 0.00015 | -2.01 | 0 | mirMAP | -0.12 | 0.00652 | NA | |
101 | hsa-miR-148a-3p | KIAA1644 | 1.27 | 0 | -4.4 | 0 | mirMAP | -0.47 | 0 | NA | |
102 | hsa-miR-148a-3p | KIF1B | 1.27 | 0 | -0.68 | 2.0E-5 | mirMAP | -0.15 | 0 | NA | |
103 | hsa-miR-148a-5p | KIFC3 | 1.16 | 0.00015 | 0.28 | 0.29292 | MirTarget | -0.23 | 0 | NA | |
104 | hsa-miR-148a-5p | KIRREL | 1.16 | 0.00015 | -1.37 | 0.00482 | mirMAP | -0.22 | 0.00367 | NA | |
105 | hsa-miR-148a-3p | KLF4 | 1.27 | 0 | -2.67 | 0 | MirTarget; miRNATAP | -0.15 | 0.01423 | NA | |
106 | hsa-miR-148a-5p | KLF9 | 1.16 | 0.00015 | -2.79 | 0 | mirMAP | -0.14 | 0.00558 | NA | |
107 | hsa-miR-148a-5p | KLHL4 | 1.16 | 0.00015 | -2.04 | 0.0002 | mirMAP | -0.36 | 3.0E-5 | NA | |
108 | hsa-miR-148a-3p | LCOR | 1.27 | 0 | -0.36 | 0.27591 | miRNATAP | -0.12 | 0.03394 | NA | |
109 | hsa-miR-148a-3p | LDLR | 1.27 | 0 | -1.42 | 7.0E-5 | miRNATAP | -0.17 | 0.00709 | NA | |
110 | hsa-miR-148a-5p | LEFTY2 | 1.16 | 0.00015 | -2.33 | 0.00054 | MirTarget | -0.32 | 0.00295 | NA | |
111 | hsa-miR-148a-5p | LMO1 | 1.16 | 0.00015 | -2.22 | 2.0E-5 | MirTarget | -0.23 | 0.00536 | NA | |
112 | hsa-miR-148a-3p | LONRF2 | 1.27 | 0 | -3.86 | 0 | mirMAP | -0.3 | 0.02183 | NA | |
113 | hsa-miR-148a-5p | LPCAT2 | 1.16 | 0.00015 | -0.31 | 0.31845 | MirTarget | -0.13 | 0.00542 | NA | |
114 | hsa-miR-148a-5p | LPL | 1.16 | 0.00015 | -0.98 | 0.02055 | mirMAP | -0.14 | 0.03533 | NA | |
115 | hsa-miR-148a-5p | LSM11 | 1.16 | 0.00015 | -0.97 | 0 | mirMAP | -0.17 | 0 | NA | |
116 | hsa-miR-148a-3p | LTBP1 | 1.27 | 0 | -1.1 | 0.00013 | MirTarget; miRNATAP | -0.12 | 0.01743 | NA | |
117 | hsa-miR-148a-5p | LTBP2 | 1.16 | 0.00015 | -0.17 | 0.61169 | mirMAP | -0.22 | 5.0E-5 | NA | |
118 | hsa-miR-148a-3p | LYNX1 | 1.27 | 0 | -2.28 | 0 | mirMAP | -0.4 | 0 | NA | |
119 | hsa-miR-148a-5p | MAP1B | 1.16 | 0.00015 | -3.18 | 0 | mirMAP; miRNATAP | -0.3 | 0 | NA | |
120 | hsa-miR-148a-5p | MAPRE2 | 1.16 | 0.00015 | -1.49 | 0 | mirMAP | -0.12 | 0.00325 | NA | |
121 | hsa-miR-148a-3p | MARCH3 | 1.27 | 0 | -0.64 | 0.02308 | MirTarget; miRNATAP | -0.16 | 0.00191 | NA | |
122 | hsa-miR-148a-3p | MITF | 1.27 | 0 | -2.11 | 0 | miRNATAP | -0.2 | 0.00143 | 20644734 | miR 148 regulates Mitf in melanoma cells; Furthermore miR-148 was shown to affect Mitf mRNA expression in melanoma cells through a conserved binding site in the 3'UTR sequence of mouse and human Mitf; Our data show that miR-148 and miR-137 present an additional level of regulating Mitf expression in melanocytes and melanoma cells |
123 | hsa-miR-148a-5p | MRC1 | 1.16 | 0.00015 | -1.55 | 0.0017 | MirTarget | -0.16 | 0.03794 | NA | |
124 | hsa-miR-148a-5p | MSRB3 | 1.16 | 0.00015 | -3.32 | 0 | mirMAP | -0.37 | 0 | NA | |
125 | hsa-miR-148a-3p | MTMR9 | 1.27 | 0 | -0.84 | 0 | miRNAWalker2 validate; MirTarget | -0.14 | 0 | NA | |
126 | hsa-miR-148a-3p | MTSS1L | 1.27 | 0 | -0.35 | 0.10973 | MirTarget; miRNATAP | -0.2 | 0 | NA | |
127 | hsa-miR-148a-3p | MXRA7 | 1.27 | 0 | -1.86 | 0 | mirMAP | -0.29 | 0 | NA | |
128 | hsa-miR-148a-3p | MYO5A | 1.27 | 0 | -0.27 | 0.31162 | mirMAP | -0.11 | 0.02373 | NA | |
129 | hsa-miR-148a-3p | NCAM1 | 1.27 | 0 | -5.47 | 0 | miRNATAP | -0.51 | 1.0E-5 | NA | |
130 | hsa-miR-148a-3p | NDST1 | 1.27 | 0 | -0.25 | 0.17674 | mirMAP; miRNATAP | -0.1 | 0.0017 | NA | |
131 | hsa-miR-148a-5p | NEURL1B | 1.16 | 0.00015 | -1.41 | 0 | mirMAP | -0.11 | 0.01473 | NA | |
132 | hsa-miR-148a-3p | NFAT5 | 1.27 | 0 | -0.39 | 0.03775 | miRNATAP | -0.1 | 0.00224 | NA | |
133 | hsa-miR-148a-3p | NOL4 | 1.27 | 0 | -3.94 | 0 | miRNATAP | -0.36 | 0.00063 | NA | |
134 | hsa-miR-148a-3p | NOVA1 | 1.27 | 0 | -4.22 | 0 | miRNATAP | -0.37 | 0.0001 | NA | |
135 | hsa-miR-148a-5p | NOVA1 | 1.16 | 0.00015 | -4.22 | 0 | miRNATAP | -0.26 | 0.00272 | NA | |
136 | hsa-miR-148a-3p | NPTN | 1.27 | 0 | -0.74 | 0 | MirTarget; miRNATAP | -0.13 | 0 | NA | |
137 | hsa-miR-148a-3p | NPTX1 | 1.27 | 0 | -3.05 | 0 | miRNATAP | -0.34 | 0.00028 | NA | |
138 | hsa-miR-148a-3p | NRP1 | 1.27 | 0 | -0.61 | 0.02915 | miRNATAP | -0.15 | 0.00242 | 26967387 | Mechanistically miR-148a appears to suppress the extravasation process of cancer cells likely by targeting two genes WNT1 and NRP1 in a cell non-autonomous manner |
139 | hsa-miR-148a-5p | NT5E | 1.16 | 0.00015 | -1.32 | 0.00558 | miRNATAP | -0.41 | 0 | NA | |
140 | hsa-miR-148a-3p | PCDH10 | 1.27 | 0 | -3.24 | 0 | miRNATAP | -0.35 | 0.0026 | NA | |
141 | hsa-miR-148a-5p | PDE4D | 1.16 | 0.00015 | -2.17 | 0 | mirMAP | -0.14 | 0.00077 | NA | |
142 | hsa-miR-148a-3p | PDE5A | 1.27 | 0 | -2.72 | 0 | MirTarget | -0.24 | 2.0E-5 | NA | |
143 | hsa-miR-148a-5p | PDE5A | 1.16 | 0.00015 | -2.72 | 0 | mirMAP | -0.14 | 0.00598 | NA | |
144 | hsa-miR-148a-5p | PDLIM5 | 1.16 | 0.00015 | -0.94 | 0 | mirMAP; miRNATAP | -0.19 | 0 | NA | |
145 | hsa-miR-148a-3p | PITPNM2 | 1.27 | 0 | -1.17 | 0 | MirTarget | -0.25 | 0 | NA | |
146 | hsa-miR-148a-3p | PITPNM3 | 1.27 | 0 | -1.79 | 3.0E-5 | mirMAP | -0.22 | 0.00363 | NA | |
147 | hsa-miR-148a-3p | PLXDC1 | 1.27 | 0 | 0 | 0.99489 | mirMAP | -0.12 | 0.01104 | NA | |
148 | hsa-miR-148a-5p | PLXNA2 | 1.16 | 0.00015 | -0.88 | 0.00059 | MirTarget; miRNATAP | -0.18 | 1.0E-5 | NA | |
149 | hsa-miR-148a-3p | PPARGC1B | 1.27 | 0 | -1.48 | 0 | miRNATAP | -0.15 | 0.00394 | NA | |
150 | hsa-miR-148a-3p | PPFIA2 | 1.27 | 0 | -2.56 | 0 | miRNATAP | -0.2 | 0.02504 | NA |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | CARDIOVASCULAR SYSTEM DEVELOPMENT | 33 | 788 | 8.136e-11 | 1.893e-07 |
2 | CIRCULATORY SYSTEM DEVELOPMENT | 33 | 788 | 8.136e-11 | 1.893e-07 |
3 | VASCULATURE DEVELOPMENT | 25 | 469 | 1.421e-10 | 2.204e-07 |
4 | CELLULAR RESPONSE TO ENDOGENOUS STIMULUS | 37 | 1008 | 2.172e-10 | 2.527e-07 |
5 | RESPONSE TO ENDOGENOUS STIMULUS | 45 | 1450 | 4.367e-10 | 4.064e-07 |
6 | CELLULAR RESPONSE TO ORGANIC SUBSTANCE | 51 | 1848 | 1.43e-09 | 9.59e-07 |
7 | REGULATION OF PHOSPHORUS METABOLIC PROCESS | 47 | 1618 | 1.443e-09 | 9.59e-07 |
8 | REGULATION OF CELLULAR COMPONENT MOVEMENT | 30 | 771 | 3.573e-09 | 2.078e-06 |
9 | REGULATION OF MUSCLE SYSTEM PROCESS | 15 | 195 | 6.433e-09 | 3.326e-06 |
10 | REGULATION OF CELL DIFFERENTIATION | 43 | 1492 | 1.055e-08 | 4.908e-06 |
11 | ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY | 27 | 689 | 2.005e-08 | 8.481e-06 |
12 | CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND | 29 | 799 | 3.077e-08 | 1.142e-05 |
13 | BLOOD VESSEL MORPHOGENESIS | 19 | 364 | 3.594e-08 | 1.142e-05 |
14 | RESPONSE TO OXYGEN CONTAINING COMPOUND | 40 | 1381 | 3.309e-08 | 1.142e-05 |
15 | MOVEMENT OF CELL OR SUBCELLULAR COMPONENT | 38 | 1275 | 3.681e-08 | 1.142e-05 |
16 | ANGIOGENESIS | 17 | 293 | 4.222e-08 | 1.228e-05 |
17 | REGULATION OF PROTEIN MODIFICATION PROCESS | 45 | 1710 | 6.799e-08 | 1.861e-05 |
18 | LOCOMOTION | 34 | 1114 | 1.221e-07 | 3.157e-05 |
19 | REGULATION OF CELL ADHESION | 24 | 629 | 2.118e-07 | 5.186e-05 |
20 | GROWTH | 19 | 410 | 2.303e-07 | 5.358e-05 |
21 | REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT | 43 | 1672 | 2.673e-07 | 5.654e-05 |
22 | DEVELOPMENTAL GROWTH | 17 | 333 | 2.645e-07 | 5.654e-05 |
23 | BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE | 11 | 131 | 2.908e-07 | 5.883e-05 |
24 | TUBE DEVELOPMENT | 22 | 552 | 3.364e-07 | 6.032e-05 |
25 | CELLULAR RESPONSE TO NITROGEN COMPOUND | 21 | 505 | 3.159e-07 | 6.032e-05 |
26 | REGULATION OF SYSTEM PROCESS | 21 | 507 | 3.371e-07 | 6.032e-05 |
27 | REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION | 42 | 1656 | 5.486e-07 | 9.455e-05 |
28 | CELL DEVELOPMENT | 38 | 1426 | 6.328e-07 | 0.0001052 |
29 | NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 21 | 541 | 9.647e-07 | 0.0001496 |
30 | NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 21 | 541 | 9.647e-07 | 0.0001496 |
31 | NEURON PROJECTION DEVELOPMENT | 21 | 545 | 1.085e-06 | 0.0001591 |
32 | TISSUE DEVELOPMENT | 39 | 1518 | 1.094e-06 | 0.0001591 |
33 | RESPONSE TO NITROGEN COMPOUND | 27 | 859 | 1.595e-06 | 0.0002121 |
34 | HEART DEVELOPMENT | 19 | 466 | 1.581e-06 | 0.0002121 |
35 | NEGATIVE REGULATION OF PHOSPHORYLATION | 18 | 422 | 1.593e-06 | 0.0002121 |
36 | HEAD DEVELOPMENT | 24 | 709 | 1.782e-06 | 0.0002303 |
37 | POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS | 30 | 1036 | 2.156e-06 | 0.0002447 |
38 | POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS | 30 | 1036 | 2.156e-06 | 0.0002447 |
39 | CENTRAL NERVOUS SYSTEM DEVELOPMENT | 27 | 872 | 2.117e-06 | 0.0002447 |
40 | NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 22 | 616 | 2.079e-06 | 0.0002447 |
41 | EXTRACELLULAR STRUCTURE ORGANIZATION | 15 | 304 | 2.077e-06 | 0.0002447 |
42 | NEURON DIFFERENTIATION | 27 | 874 | 2.21e-06 | 0.0002449 |
43 | REGULATION OF KINASE ACTIVITY | 25 | 776 | 2.591e-06 | 0.0002804 |
44 | TISSUE MORPHOGENESIS | 20 | 533 | 2.957e-06 | 0.0003128 |
45 | NEUROGENESIS | 36 | 1402 | 3.067e-06 | 0.0003171 |
46 | MORPHOGENESIS OF AN EPITHELIUM | 17 | 400 | 3.286e-06 | 0.0003253 |
47 | MORPHOGENESIS OF A BRANCHING STRUCTURE | 11 | 167 | 3.24e-06 | 0.0003253 |
48 | ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS | 28 | 957 | 4.002e-06 | 0.000388 |
49 | CARDIAC MUSCLE TISSUE DEVELOPMENT | 10 | 140 | 4.435e-06 | 0.0004127 |
50 | TUBE MORPHOGENESIS | 15 | 323 | 4.359e-06 | 0.0004127 |
51 | NEGATIVE REGULATION OF CELL COMMUNICATION | 32 | 1192 | 4.705e-06 | 0.0004293 |
52 | REGULATION OF EPITHELIAL CELL PROLIFERATION | 14 | 285 | 4.816e-06 | 0.0004298 |
53 | TISSUE MIGRATION | 8 | 84 | 4.895e-06 | 0.0004298 |
54 | REGULATION OF MUSCLE CONTRACTION | 10 | 147 | 6.854e-06 | 0.0005906 |
55 | RESPONSE TO GROWTH FACTOR | 18 | 475 | 8.236e-06 | 0.0006968 |
56 | EPITHELIUM DEVELOPMENT | 27 | 945 | 9.285e-06 | 0.0007449 |
57 | CELL MOTILITY | 25 | 835 | 9.26e-06 | 0.0007449 |
58 | LOCALIZATION OF CELL | 25 | 835 | 9.26e-06 | 0.0007449 |
59 | POSITIVE REGULATION OF MOLECULAR FUNCTION | 41 | 1791 | 9.868e-06 | 0.0007782 |
60 | NEURON DEVELOPMENT | 22 | 687 | 1.176e-05 | 0.0009065 |
61 | POSITIVE REGULATION OF BIOSYNTHETIC PROCESS | 41 | 1805 | 1.188e-05 | 0.0009065 |
62 | TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY | 18 | 498 | 1.558e-05 | 0.001169 |
63 | POSITIVE REGULATION OF CATALYTIC ACTIVITY | 36 | 1518 | 1.776e-05 | 0.001312 |
64 | CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS | 4 | 15 | 1.965e-05 | 0.001429 |
65 | MUSCLE SYSTEM PROCESS | 13 | 282 | 2.07e-05 | 0.001459 |
66 | CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION | 15 | 368 | 2.053e-05 | 0.001459 |
67 | CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION | 18 | 513 | 2.31e-05 | 0.001597 |
68 | CELL GROWTH | 9 | 135 | 2.335e-05 | 0.001597 |
69 | DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS | 8 | 104 | 2.384e-05 | 0.001608 |
70 | POSITIVE REGULATION OF LOCOMOTION | 16 | 420 | 2.485e-05 | 0.001652 |
71 | RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE | 4 | 16 | 2.597e-05 | 0.001702 |
72 | NEGATIVE REGULATION OF RESPONSE TO STIMULUS | 33 | 1360 | 2.645e-05 | 0.001709 |
73 | PATTERNING OF BLOOD VESSELS | 5 | 32 | 2.768e-05 | 0.001764 |
74 | NEGATIVE REGULATION OF KINASE ACTIVITY | 12 | 250 | 2.909e-05 | 0.001829 |
75 | ORGAN MORPHOGENESIS | 24 | 841 | 3.07e-05 | 0.001905 |
76 | REGULATION OF CALCINEURIN NFAT SIGNALING CASCADE | 4 | 17 | 3.366e-05 | 0.002061 |
77 | MUSCLE STRUCTURE DEVELOPMENT | 16 | 432 | 3.49e-05 | 0.002109 |
78 | POSITIVE REGULATION OF DEVELOPMENTAL PROCESS | 29 | 1142 | 3.816e-05 | 0.002276 |
79 | REGULATION OF HYDROLASE ACTIVITY | 32 | 1327 | 4.005e-05 | 0.002359 |
80 | NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS | 28 | 1087 | 4.091e-05 | 0.002379 |
81 | ENDOTHELIAL CELL MIGRATION | 6 | 57 | 4.37e-05 | 0.00251 |
82 | REGULATION OF HEART CONTRACTION | 11 | 221 | 4.512e-05 | 0.00256 |
83 | POSITIVE REGULATION OF OSSIFICATION | 7 | 84 | 4.642e-05 | 0.002602 |
84 | REGULATION OF RECEPTOR ACTIVITY | 8 | 117 | 5.567e-05 | 0.003084 |
85 | NEURON PROJECTION MORPHOGENESIS | 15 | 402 | 5.652e-05 | 0.003094 |
86 | REGULATION OF MUSCLE HYPERTROPHY | 5 | 37 | 5.721e-05 | 0.003096 |
87 | FOREBRAIN DEVELOPMENT | 14 | 357 | 5.897e-05 | 0.003154 |
88 | SKELETAL SYSTEM DEVELOPMENT | 16 | 455 | 6.458e-05 | 0.003412 |
89 | AMEBOIDAL TYPE CELL MIGRATION | 9 | 154 | 6.569e-05 | 0.003412 |
90 | RELAXATION OF MUSCLE | 4 | 20 | 6.673e-05 | 0.003412 |
91 | POSITIVE REGULATION OF CHEMOTAXIS | 8 | 120 | 6.664e-05 | 0.003412 |
92 | NEGATIVE REGULATION OF CATALYTIC ACTIVITY | 23 | 829 | 6.947e-05 | 0.003514 |
93 | REGULATION OF TRANSFERASE ACTIVITY | 25 | 946 | 7.254e-05 | 0.003584 |
94 | ENDOTHELIUM DEVELOPMENT | 7 | 90 | 7.231e-05 | 0.003584 |
95 | REGULATION OF CELL PROLIFERATION | 34 | 1496 | 7.318e-05 | 0.003584 |
96 | CONNECTIVE TISSUE DEVELOPMENT | 10 | 194 | 7.487e-05 | 0.003629 |
97 | REGULATION OF MUSCLE ADAPTATION | 6 | 63 | 7.734e-05 | 0.00371 |
98 | POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS | 28 | 1135 | 8.64e-05 | 0.004102 |
99 | REGULATION OF CARDIAC CONDUCTION | 6 | 66 | 0.0001005 | 0.004726 |
100 | SYNAPTIC SIGNALING | 15 | 424 | 0.0001024 | 0.004766 |
101 | POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 6 | 68 | 0.0001189 | 0.005476 |
102 | REGULATION OF ENDOTHELIAL CELL PROLIFERATION | 7 | 98 | 0.0001241 | 0.005659 |
103 | REGULATION OF AXONOGENESIS | 9 | 168 | 0.000128 | 0.005771 |
104 | POSITIVE REGULATION OF AXONOGENESIS | 6 | 69 | 0.000129 | 0.005771 |
105 | SECRETION BY CELL | 16 | 486 | 0.0001386 | 0.006141 |
106 | BLOOD VESSEL ENDOTHELIAL CELL MIGRATION | 4 | 24 | 0.0001412 | 0.006164 |
107 | REGULATION OF BLOOD CIRCULATION | 12 | 295 | 0.0001417 | 0.006164 |
108 | CHEMICAL HOMEOSTASIS | 23 | 874 | 0.000152 | 0.00655 |
109 | POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS | 33 | 1492 | 0.0001575 | 0.006724 |
110 | ENDOTHELIAL CELL DIFFERENTIATION | 6 | 72 | 0.0001634 | 0.006913 |
111 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM | 4 | 25 | 0.0001667 | 0.006987 |
112 | RESPONSE TO ALKALOID | 8 | 137 | 0.0001683 | 0.006991 |
113 | POSITIVE REGULATION OF CELL DIFFERENTIATION | 22 | 823 | 0.0001706 | 0.007025 |
114 | CELLULAR RESPONSE TO ACID CHEMICAL | 9 | 175 | 0.0001743 | 0.007112 |
115 | REGULATION OF MAPK CASCADE | 19 | 660 | 0.0001902 | 0.007696 |
116 | NEUROMUSCULAR SYNAPTIC TRANSMISSION | 4 | 26 | 0.0001952 | 0.007831 |
117 | REGULATION OF OSSIFICATION | 9 | 178 | 0.0001979 | 0.007872 |
118 | ARTERY DEVELOPMENT | 6 | 75 | 0.0002048 | 0.008008 |
119 | REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL | 6 | 75 | 0.0002048 | 0.008008 |
120 | REGULATION OF SEQUESTERING OF CALCIUM ION | 7 | 107 | 0.0002146 | 0.008074 |
121 | EMBRYO DEVELOPMENT | 23 | 894 | 0.0002109 | 0.008074 |
122 | REGULATION OF CHEMOTAXIS | 9 | 180 | 0.0002152 | 0.008074 |
123 | PLATELET DEGRANULATION | 7 | 107 | 0.0002146 | 0.008074 |
124 | REGULATION OF CELL DEVELOPMENT | 22 | 836 | 0.0002125 | 0.008074 |
125 | REGULATION OF CALCIUM MEDIATED SIGNALING | 6 | 76 | 0.0002203 | 0.008157 |
126 | REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER | 37 | 1784 | 0.0002209 | 0.008157 |
127 | NEGATIVE REGULATION OF MOLECULAR FUNCTION | 26 | 1079 | 0.0002272 | 0.0082 |
128 | EXOCYTOSIS | 12 | 310 | 0.0002242 | 0.0082 |
129 | MUCOPOLYSACCHARIDE METABOLIC PROCESS | 7 | 108 | 0.0002273 | 0.0082 |
130 | RESPONSE TO WOUNDING | 17 | 563 | 0.0002395 | 0.008322 |
131 | POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS | 31 | 1395 | 0.000234 | 0.008322 |
132 | REGULATION OF NEURON PROJECTION DEVELOPMENT | 14 | 408 | 0.0002383 | 0.008322 |
133 | DEVELOPMENTAL CELL GROWTH | 6 | 77 | 0.0002367 | 0.008322 |
134 | CELL PROJECTION ORGANIZATION | 23 | 902 | 0.0002397 | 0.008322 |
135 | POSITIVE REGULATION OF GENE EXPRESSION | 36 | 1733 | 0.0002635 | 0.009014 |
136 | REGULATION OF SPROUTING ANGIOGENESIS | 4 | 28 | 0.0002627 | 0.009014 |
137 | CARTILAGE DEVELOPMENT | 8 | 147 | 0.0002724 | 0.009055 |
138 | REGULATION OF STRIATED MUSCLE CONTRACTION | 6 | 79 | 0.0002723 | 0.009055 |
139 | CELL FATE COMMITMENT | 10 | 227 | 0.0002702 | 0.009055 |
140 | REGULATION OF CELL DEATH | 32 | 1472 | 0.0002724 | 0.009055 |
141 | CELLULAR RESPONSE TO EPINEPHRINE STIMULUS | 3 | 12 | 0.0002905 | 0.009587 |
142 | NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE | 5 | 52 | 0.0002973 | 0.009742 |
143 | REGULATION OF THE FORCE OF HEART CONTRACTION | 4 | 29 | 0.000302 | 0.009828 |
144 | MUSCLE TISSUE DEVELOPMENT | 11 | 275 | 0.0003092 | 0.009991 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | MOLECULAR FUNCTION REGULATOR | 35 | 1353 | 3.644e-06 | 0.003385 |
2 | GROWTH FACTOR BINDING | 9 | 123 | 1.105e-05 | 0.005132 |
3 | TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY | 7 | 81 | 3.667e-05 | 0.007988 |
4 | PROTEIN COMPLEX BINDING | 25 | 935 | 6.019e-05 | 0.007988 |
5 | ENZYME REGULATOR ACTIVITY | 26 | 959 | 3.368e-05 | 0.007988 |
6 | ENZYME BINDING | 38 | 1737 | 5.914e-05 | 0.007988 |
7 | PHOSPHATASE REGULATOR ACTIVITY | 7 | 87 | 5.819e-05 | 0.007988 |
Num | GO | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|
1 | NEURON PROJECTION | 34 | 942 | 1.987e-09 | 1.16e-06 |
2 | NEURON PART | 39 | 1265 | 9.416e-09 | 2.749e-06 |
3 | SOMATODENDRITIC COMPARTMENT | 26 | 650 | 2.484e-08 | 4.835e-06 |
4 | DENDRITE | 20 | 451 | 2.216e-07 | 3.235e-05 |
5 | EXTRACELLULAR MATRIX | 19 | 426 | 4.131e-07 | 4.825e-05 |
6 | CELL JUNCTION | 33 | 1151 | 7.847e-07 | 7.638e-05 |
7 | CELL PROJECTION | 43 | 1786 | 1.566e-06 | 0.0001307 |
8 | SYNAPSE | 24 | 754 | 5.108e-06 | 0.0003544 |
9 | CELL SURFACE | 24 | 757 | 5.462e-06 | 0.0003544 |
10 | CELL CELL JUNCTION | 15 | 383 | 3.258e-05 | 0.001903 |
11 | PROTEINACEOUS EXTRACELLULAR MATRIX | 14 | 356 | 5.722e-05 | 0.003038 |
12 | SARCOLEMMA | 8 | 125 | 8.889e-05 | 0.004326 |
13 | PLATELET ALPHA GRANULE | 6 | 75 | 0.0002048 | 0.007011 |
14 | INTRINSIC COMPONENT OF PLASMA MEMBRANE | 35 | 1649 | 0.0002161 | 0.007011 |
15 | EXTRACELLULAR SPACE | 31 | 1376 | 0.0001839 | 0.007011 |
16 | CELL BODY | 16 | 494 | 0.0001669 | 0.007011 |
17 | MEMBRANE REGION | 27 | 1134 | 0.0002073 | 0.007011 |
18 | SYNAPSE PART | 18 | 610 | 0.0002083 | 0.007011 |
Num | Pathway | Pathview | Overlap | Size | P Value | Adj. P Value |
---|---|---|---|---|---|---|
1 | cGMP_PKG_signaling_pathway_hsa04022 | 11 | 163 | 2.56e-06 | 0.0001081 | |
2 | Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 | 10 | 139 | 4.159e-06 | 0.0001081 | |
3 | FoxO_signaling_pathway_hsa04068 | 9 | 132 | 1.951e-05 | 0.0003382 | |
4 | cAMP_signaling_pathway_hsa04024 | 9 | 198 | 0.0004342 | 0.005645 | |
5 | PI3K_Akt_signaling_pathway_hsa04151 | 12 | 352 | 0.0006992 | 0.007272 | |
6 | Apelin_signaling_pathway_hsa04371 | 7 | 137 | 0.0009523 | 0.008254 | |
7 | Calcium_signaling_pathway_hsa04020 | 8 | 182 | 0.001117 | 0.008295 | |
8 | Hippo_signaling_pathway_hsa04390 | 7 | 154 | 0.001871 | 0.01135 | |
9 | Focal_adhesion_hsa04510 | 8 | 199 | 0.001965 | 0.01135 | |
10 | AMPK_signaling_pathway_hsa04152 | 6 | 121 | 0.002546 | 0.01247 | |
11 | TGF_beta_signaling_pathway_hsa04350 | 5 | 84 | 0.002638 | 0.01247 | |
12 | MAPK_signaling_pathway_hsa04010 | 9 | 295 | 0.006558 | 0.02775 | |
13 | p53_signaling_pathway_hsa04115 | 4 | 68 | 0.007353 | 0.02775 | |
14 | mTOR_signaling_pathway_hsa04150 | 6 | 151 | 0.007471 | 0.02775 | |
15 | Rap1_signaling_pathway_hsa04015 | 7 | 206 | 0.009111 | 0.03113 | |
16 | Regulation_of_actin_cytoskeleton_hsa04810 | 7 | 208 | 0.009578 | 0.03113 | |
17 | Oocyte_meiosis_hsa04114 | 5 | 124 | 0.01341 | 0.04039 | |
18 | ECM_receptor_interaction_hsa04512 | 4 | 82 | 0.01398 | 0.04039 | |
19 | Autophagy_animal_hsa04140 | 5 | 128 | 0.0152 | 0.04161 | |
20 | Wnt_signaling_pathway_hsa04310 | 5 | 146 | 0.02524 | 0.06563 | |
21 | HIF_1_signaling_pathway_hsa04066 | 4 | 100 | 0.02683 | 0.06644 | |
22 | Hippo_signaling_pathway_multiple_species_hsa04392 | 2 | 29 | 0.04226 | 0.09989 | |
23 | Sphingolipid_signaling_pathway_hsa04071 | 4 | 118 | 0.045 | 0.1017 | |
24 | Ras_signaling_pathway_hsa04014 | 6 | 232 | 0.0486 | 0.1053 | |
25 | Gap_junction_hsa04540 | 3 | 88 | 0.07782 | 0.1619 | |
26 | Cellular_senescence_hsa04218 | 4 | 160 | 0.1081 | 0.2162 | |
27 | Tight_junction_hsa04530 | 4 | 170 | 0.127 | 0.2447 | |
28 | Cytokine_cytokine_receptor_interaction_hsa04060 | 5 | 270 | 0.1913 | 0.3553 | |
29 | Cell_adhesion_molecules_.CAMs._hsa04514 | 3 | 145 | 0.2257 | 0.4048 | |
30 | Endocytosis_hsa04144 | 4 | 244 | 0.2979 | 0.5007 | |
31 | Phosphatidylinositol_signaling_system_hsa04070 | 2 | 99 | 0.3082 | 0.5007 | |
32 | TNF_signaling_pathway_hsa04668 | 2 | 108 | 0.3454 | 0.5442 | |
33 | Phospholipase_D_signaling_pathway_hsa04072 | 2 | 146 | 0.4929 | 0.712 | |
34 | Phagosome_hsa04145 | 2 | 152 | 0.5143 | 0.7154 | |
35 | Neuroactive_ligand_receptor_interaction_hsa04080 | 3 | 278 | 0.6108 | 0.7865 |